Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants

Venkatesh Sampath1, Jeffery S Garland2, Daniel Helbling1

  • 1Department of Pediatrics, Medical College of Wisconsin, and Children's Research Institute, Children's Hospital and Health Systems, Milwaukee, Wisconsin.

Pediatric Research
|December 18, 2014
PubMed

Insights

Genetic variants in antioxidant response elements (ARE) may influence bronchopulmonary dysplasia (BPD) risk in premature infants. Specific NQO1 and NFE2L2 gene variants were linked to BPD development and severity.

Area of Science:

  • Genetics
  • Neonatal Medicine
  • Oxidative Stress Biology

Background:

  • Oxidative stress-induced lung injury is a key factor in bronchopulmonary dysplasia (BPD) pathogenesis.
  • The NFE2L2-ARE pathway regulates cellular defense against oxidative stress.
  • Genetic variations in ARE-containing genes may affect infant susceptibility to BPD.

Purpose of the Study:

  • To investigate the association between genetic variants in ARE-related genes and the risk/severity of BPD in very-low-birth-weight (VLBW) infants.
  • To determine if specific single nucleotide polymorphisms (SNPs) in genes like NFE2L2, NQO1, and others influence BPD outcomes.

Main Methods:

  • Genotyping of variants in SOD2, NFE2L2, GCLC, GSTP1, HMOX1, and NQO1 genes in VLBW infants.
  • Utilized TaqMan probes for SNP genotyping and analyzed data with ABI HT7900.
  • Employed genetic dominance and recessive models to assess SNP associations with BPD.

Main Results:

  • A hypomorphic NQO1 SNP (rs1800566) in homozygous state was linked to increased BPD incidence.
  • An NFE2L2 SNP (rs6721961) was associated with reduced severe BPD in the entire cohort and Caucasian infants.
  • Adjusted regression models confirmed associations between NQO1 SNPs and BPD, and NFE2L2 SNPs and severe BPD.

Conclusions:

  • Genetic variants within the NFE2L2-ARE pathway may contribute to BPD susceptibility variability in preterm infants.
  • These findings suggest a potential genetic component influencing BPD development.
  • Further validation in independent cohorts is necessary to confirm these associations.
Abstract

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
74
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
3
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
20.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.3K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
21
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
4.3K